Crossmark

AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole

Crossref DOI link: https://doi.org/10.1007/s10067-022-06443-1

Published Online: 2022-11-24

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Duan, Mengyuan

Shen, Min

Zhou, Yongting

He, Yi

Guo, Zehao

Ye, Caiying

Li, Juan

Zhu, Lei https://orcid.org/0000-0003-3471-1663
License Information

Text and Data Mining valid from 2022-11-24

Version of Record valid from 2022-11-24
More Information

Article History

Received: 1 February 2022

Revised: 13 October 2022

Accepted: 2 November 2022

First Online: 24 November 2022

Declarations

:

: The Institutional Review Board of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences approved this project (002–2018), and each participant’s written consent was obtained according to the Declaration of Helsinki.

: None.

Document is current

Any future updates will be listed below